First Time Loading...
L

Link-Asia International Medtech Group Ltd
HKEX:1143

Watchlist Manager
Link-Asia International Medtech Group Ltd
HKEX:1143
Watchlist
Price: 2.07 HKD 0.98% Market Closed
Updated: May 12, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

776.4m
+8%
Assets
Growth Rates:
1 Year
+18%
3 Years
+18%
5 Years
-17%
7 Years
-3%
10 Years
-32%
289.8m
+7%
Liabilities
Growth Rates:
1 Year
-3%
3 Years
-20%
5 Years
-19%
7 Years
-11%
10 Years
-62%
486.7m
+9%
Equity
Growth Rates:
1 Year
+35%
3 Years
+65%
5 Years
-15%
7 Years
+2%
10 Years
+29%

Balance Sheet Decomposition
Link-Asia International Medtech Group Ltd

776.4m
Assets
289.8m
Liabilities
776.4m
Assets
289.8m
Liabilities
Current Assets 705.9m
Cash & Short-Term Investments 389m
Receivables 175.1m
Other Current Assets 141.8m
Non-Current Assets 70.5m
PP&E 33.1m
Intangibles 34.1m
Other Non-Current Assets 3.3m
Current Liabilities 272.7m
Accounts Payable 76.5m
Accrued Liabilities 179.8m
Short-Term Debt 4.8m
Other Current Liabilities 11.6m
Non-Current Liabilities 17.1m
Long-Term Debt 15m
Other Non-Current Liabilities 2.1m

Balance Sheet
Link-Asia International Medtech Group Ltd

Rotate your device to view
Balance Sheet
Currency: HKD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
186
441
208
479
354
156
150
146
252
389
Cash
186
441
208
479
354
156
150
146
128
272
Cash Equivalents
0
0
0
0
0
0
0
0
125
117
Short-Term Investments
0
0
130
12
5
89
18
1
0
0
Total Receivables
390
171
137
214
258
169
237
235
185
175
Accounts Receivables
316
169
132
117
156
131
165
162
115
145
Other Receivables
74
1
5
97
102
38
72
72
70
30
Inventory
290
130
101
85
114
80
93
119
57
55
Other Current Assets
53
16
155
58
18
69
14
54
41
205
Total Current Assets
919
758
731
848
749
563
512
554
535
706
PP&E Net
105
72
61
58
52
95
68
84
54
33
PP&E Gross
105
0
61
0
52
95
68
84
54
33
Accumulated Depreciation
0
0
123
0
135
141
143
137
127
131
Intangible Assets
0
6
0
0
0
0
35
37
68
34
Goodwill
8
0
0
19
19
0
0
0
0
0
Note Receivable
0
0
0
0
45
26
0
0
0
0
Long-Term Investments
0
0
0
30
52
40
42
0
0
0
Other Long-Term Assets
19
17
8
6
14
11
0
3
1
3
Other Assets
8
0
0
19
19
0
0
0
0
0
Total Assets
1 092
N/A
853
-22%
800
-6%
961
+20%
931
-3%
735
-21%
657
-11%
678
+3%
659
-3%
776
+18%
Liabilities
Accounts Payable
281
117
81
75
76
54
87
59
40
76
Accrued Liabilities
233
144
146
169
167
150
167
146
167
154
Short-Term Debt
0
0
80
43
40
21
19
1
14
5
Current Portion of Long-Term Debt
0
0
0
0
0
26
21
22
17
7
Other Current Liabilities
76
25
24
15
65
39
37
46
39
30
Total Current Liabilities
706
285
331
302
348
291
331
273
276
273
Long-Term Debt
0
0
0
0
0
33
31
39
21
15
Deferred Income Tax
17
8
4
4
0
0
0
0
0
0
Minority Interest
18
6
11
1
10
0
0
0
2
2
Other Liabilities
30
12
2
0
0
0
0
0
0
0
Total Liabilities
722
N/A
299
-59%
325
+9%
306
-6%
358
+17%
324
-10%
362
+12%
312
-14%
299
-4%
290
-3%
Equity
Common Stock
4
5
5
6
6
6
9
18
24
39
Retained Earnings
214
549
136
649
3
177
398
440
492
484
Additional Paid In Capital
0
0
308
0
604
604
670
773
814
926
Unrealized Security Profit/Loss
0
0
13
0
54
37
0
0
0
0
Other Equity
0
0
14
0
14
15
16
15
15
6
Total Equity
370
N/A
554
+50%
475
-14%
655
+38%
573
-12%
411
-28%
295
-28%
366
+24%
360
-2%
487
+35%
Total Liabilities & Equity
1 092
N/A
853
-22%
800
-6%
961
+20%
931
-3%
735
-21%
657
-11%
678
+3%
659
-3%
776
+18%
Shares Outstanding
Common Shares Outstanding
4 117
248
254
305
305
305
44
92
121
196

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.